DrugSep 27, 2023
AMMAN PHARMACEUTICAL INDUSTRIES TRP Natural Eyes, Allergy Eyes Relief, Sterile Eye Drops recall — FDA D-1152-2023
Lack of Assurance of Sterility
Class IIFDA: OngoingAMMAN PHARMACEUTICAL INDUSTRIES
Latest records
Latest recalls — page 239
The newest recall records with useful source details are listed here.
DrugSep 27, 2023
Humanrace Suncare, Ozone Body Protection Cream, Broad Spectrum Sunscreen SPF 30, packaged as recall — FDA D-1176-2023
Subpotent Drug: Product does not contain SPF that is declared on the label.
Class IIFDA: OngoingHUMANRACE
DrugSep 27, 2023
Humanrace Suncare, Ozone Face Protection Daily Moisturizer, Broad Spectrum Sunscreen SPF 30 recall — FDA D-1175-2023
Subpotent Drug: Product does not contain SPF that is declared on the label.
Class IIFDA: OngoingHUMANRACE
DrugSep 27, 2023
CHLORAPREP ONE-STEP BD ChloraPrep Clear, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v recall — FDA D-1168-2023
Stability data does not support expiry: Shelf-life of the impacted lots of BD ChloraPrep" Clear 1 mL Applicator cannot be substantiated beyond 12-months although labeled with 36-month…
Class IIFDA: CompletedCareFusion 213, LLC
VehicleSep 22, 2023
Forte lower arm recall — NHTSA campaign 23V649000
Kia America, Inc. (Kia) is recalling certain 2023 Forte vehicles. The right front lower control arm may have been improperly welded, which can cause it to fail.
lower armKia America, Inc.
VehicleSep 21, 2023
Subaru of driveshaft recall — NHTSA campaign 23V647000
Subaru of America, Inc. (Subaru) is recalling certain 2023 Outback, Legacy, Ascent, and Impreza vehicles. The center support bolts for the driveshaft may loosen, resulting in the…
driveshaftSubaru of America, Inc.
VehicleSep 20, 2023
General Motors rear recall — NHTSA campaign 23V642000
General Motors, LLC (GM) is recalling certain 2023 Cadillac Escalade, Escalade ESV, Chevrolet Suburban, Chevrolet Tahoe, GMC Yukon, and Yukon XL vehicles. The rear suspension outer control…
rearGeneral Motors, LLC
DrugSep 20, 2023
Pantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged recall — FDA D-1148-2023
Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
Class IIFDA: TerminatedBE PHARMACEUTICALS AG
DrugSep 20, 2023
Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle) recall — FDA D-1149-2023
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
Class IIFDA: TerminatedVistaPharm LLC
DrugSep 20, 2023
Hua Da Trading, Inc. dba Wefun WEFUN Capsules 825 mg, 1x10 blister pack per carton recall — FDA D-1180-2023
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil, an ingredient found in a FDA approved product for the treatment of male sexual…
Class IFDA: TerminatedHua Da Trading, Inc. dba Wefun Inc.
VehicleSep 18, 2023
Chrysler manual transmission recall — NHTSA campaign 23V641000
Chrysler (FCA US), LLC is recalling certain 2022-2023 Jeep Wrangler and Gladiator vehicles equipped with a manual transmission. The rearview camera may fail to display the rearview image…
manual transmissionChrysler (FCA US, LLC)
VehicleSep 15, 2023
Sorento camera recall — NHTSA campaign 23V639000
Kia America, Inc. (Kia) is recalling certain 2019 Sorento vehicles. Due to a manufacturing error, water may leak into the rearview camera, which can cause the rearview camera image not to…
cameraKia America, Inc.
DrugSep 13, 2023
Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet recall — FDA D-1145-2023
Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability.
Class IIIFDA: TerminatedAscend Laboratories, LLC
DrugSep 13, 2023
Marlex Pharmaceuticals Digoxin Tablets, USP 0.125mg, 100-count bottles recall — FDA D-1169-2023
Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP…
Class IFDA: TerminatedMarlex Pharmaceuticals, Inc.
DrugSep 13, 2023
Marlex Pharmaceuticals Digoxin Tablets, USP 0.25mg, 100-count bottles recall — FDA D-1170-2023
Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP…
Class IIFDA: TerminatedMarlex Pharmaceuticals, Inc.
DrugSep 13, 2023
Sodium Fluoride 1.1%, SODIUM FLUORIDE Prescription Dental Toothpaste, 5000 ppm Fluoride Plus recall — FDA D-1146-2023
Cases of Sodium Fluoride 1.1% Prescription Dental Toothpaste may contain cartons labeled as Capsaicin Cream 0.025% but contain correctly labeled tubes of Sodium Fluoride 1.1% Prescription…
Class IIFDA: TerminatedAVKARE LLC
DrugSep 13, 2023
Capsaicin Cream 0.025%, External Analgesic Cream, Penetrating Pain Relief, NET WT. 2.1 OZ. recall — FDA D-1147-2023
Product mix-up: Cartons labeled Capsaicin Cream 0.025% may contain tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste
Class IIFDA: TerminatedAVKARE LLC
DrugSep 13, 2023
Milrinone Lactate Injection, USP 20mg/20 mL (1mg/mL) recall — FDA D-1144-2023
Failed Impurities/Degradation Specifications
Class IIIFDA: TerminatedCaplin Steriles Limited
VehicleSep 8, 2023
Ford traction battery recall — NHTSA campaign 23V626000
Ford Motor Company (Ford) is recalling certain 2020-2022 Lincoln Aviator and Ford Explorer vehicles equipped with 3.0L PHEV engines. A manufacturing defect in one or more of the high…
traction batteryFord Motor Company
VehicleSep 8, 2023
Nissan camera recall — NHTSA campaign 23V628000
Nissan North America, Inc. (Nissan) is recalling certain 2019-2021 Altima and 2020-2021 Sentra vehicles. Damage to the camera harness can cause distortion or loss of the rearview camera…
cameraNissan North America, Inc.
DrugSep 6, 2023
APG SEVEN Vegetal Vigra, 200mg capsules, 8-count bottle, Manufacturer: Hand-shaking (Int'l) recall — FDA D-1150-2023
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil an ingredient found in a FDA approved product for the treatment of male sexual…
Class IFDA: OngoingAPG SEVEN, Inc.
DrugSep 6, 2023
Central Admixture Pharmacy Services Neonatal TPN Starter Bag, Amino Acids (trophamine) recall — FDA D-1117-2023
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugSep 6, 2023
Central Admixture Pharmacy Services EPINEPHrine added to 0.9% sodium chloride, 4mg/250mL recall — FDA D-1130-2023
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugSep 6, 2023
Central Admixture Pharmacy Services Cardioplegia Solution, low K, Maintenance 4:1 recall — FDA D-1111-2023
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026149 records · 4 categoriesJuly 2026371 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026340 records · 4 categoriesApril 2026415 records · 4 categoriesMarch 2026190 records · 4 categoriesFebruary 2026331 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025389 records · 4 categoriesNovember 2025326 records · 4 categoriesOctober 2025455 records · 4 categoriesSeptember 2025180 records · 4 categories